Barry J. Oliver
Advertisement
Barry J. Oliver, vice president, Quality, Catalent Cell, Gene & Protein Therapies.
Articles by Barry J. Oliver
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
4
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
5